Abstracts tagged "Patient Satisfaction"

Abstract Number: 2862 • 2014 ACR/ARHP Annual Meeting
Satisfaction Following Total Knee Replacement: Journey or Destination?
Jeffrey N. Katz¹, Yan Dong², Jamie E. Collins², John Wright³, David Dalury⁴, Kirk Kindsfater⁵ and Elena Losina², ¹Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ²Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, ⁴Townson Orthopedics, Maryland, Baltimore, MD, ⁵Orthopedic Center for the Rockies, Ft. Collins, CO
Background/Purpose: Total knee replacement (TKR) outcome is often assessed with measures of pain and function (fxn), but there is no consensus on whether surgery should…
Abstract Number: 1332 • 2014 ACR/ARHP Annual Meeting
From Social Support to Information Sharing, How Are Persons with Rheumatoid Arthritis Using Disease-Specific Facebook Communities? a Content Analysis
Cheryl Crow and Kristin Jones, Occupational Therapy, Samuel Merritt University, Oakland, CA
Background/Purpose: High perceived social support is associated with better quality of life and lower rates of depression for persons with rheumatoid arthritis (Minnock, et al…
Abstract Number: 2311 • 2013 ACR/ARHP Annual Meeting
Impact Of Healing Architecture In a Rheumatology Outpatient Clinic
Gunhild Bukh¹, Erik Kehn Jensen², Anne Marie Munk Tommerup³ and Ole Rintek Madsen⁴, ¹Dept. of Rheumatology, Copenhagen University Hospital Gentofte, Hellerup, Denmark, ²Kehn & Warnøe, Copenhagen, Denmark, ³Danish Architecture Centre, Copenhagen, Denmark, ⁴Copenhagen University Hospital Gentofte, Copenhagen, Denmark
Background/Purpose: Healing Architecture (HA) is a design concept primarily aimed at reducing factors of stress in the physical environment both for the patient and for…
Abstract Number: 1923 • 2013 ACR/ARHP Annual Meeting
A Study To Determine Patient Satisfaction With a Nurse-Led Injection Clinic In Rheumatology
Margaret Saldanha¹, Kathleen Brown², Dawn Heap¹, Cynthia Mech³, Melissa Deamude¹, Kathy Kislinsky¹, Debbie McClory⁴, Alpesh Shah⁵ and William G. Bensen⁶, ¹Dr. William G. Bensen, Rheumatology Health Team, St. Joseph's Hospital Hamilton, Hamilton, ON, Canada, ²Dr. William Bensen Rheumatology Clinic, Rheumatology Health Team, St. Joseph's Hospital Hamilton, Hamilton, ON, Canada, ³Dr. William G. Bensen, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ⁴Dr. William G. Bensen Rheumatology Clinic, Rheumatology Health Team Hamilton, Hamilton, ON, Canada, ⁵Epidemiology and Biostatistics, University of Western Ontario, MSc in Clinical Epidemiology, University of Western Ontario, London, ON, Canada, ⁶Department of Medicine, Division of Rheumatology, Clinical Professor, McMaster University, Hamilton, ON, Canada
Background/Purpose: There is a widening care gap in Canada between patients who need Rheumatology care and the capacity of the system to deliver that care…
Abstract Number: 589 • 2013 ACR/ARHP Annual Meeting
A Survey Of Physician and Patient Satisfaction With Control Of Systemic Lupus Erythematosus and Lupus Nephritis
Neelufar Mozaffarian¹, Steve Lobosco² and Adam Roughley², ¹AbbVie, North Chicago, IL, ²Adelphi Real World Ltd., Macclesfield, United Kingdom
Background/Purpose: Patient satisfaction with disease control is an important component of overall health and well-being. Current treatment options for systemic lupus erythematosus (SLE) ±lupus nephritis…
Abstract Number: 194 • 2013 ACR/ARHP Annual Meeting
Team Managed Care From a Patient’s Perspective: A Study Of Biological Patients At a Canadian Centre
Dawn Heap¹, Margaret Saldanha¹, Melissa Deamude¹, Cynthia Mech², Helena Ross¹, Kathy Kislinsky¹, Lauri Vanstone³, Arthur N. Lau⁴ and William G. Bensen⁵, ¹Dr. William G. Bensen, Rheumatology Health Team, St. Joseph's Hospital Hamilton, Hamilton, ON, Canada, ²Dr. William G. Bensen, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ³Dr. William Bensen Rheumatology Biologic Clinic, Rheumatology Health Team, Hamilton, ON, Canada, ⁴Rheumatology and Clinical Epidemiology, Division of Rheumatology, McMaster University, Hamilton, ON, Canada, ⁵Department of Medicine, Division of Rheumatology, Clinical Professor, McMaster University, Hamilton, ON, Canada
Background/Purpose: In Canada, there is a widening care gap in Inflammatory Arthritis due to the increased aging population, higher disease prevalence, dwindling numbers of practicing…
Abstract Number: 2259 • 2012 ACR/ARHP Annual Meeting
Limitations of Current Treatment for Systemic Lupus Erythematosus: A Patient and Physician Survey
V. Strand¹, C. Galateanu², S. Lobosco³, D.S. Pushparajah², J. Sayers⁴ and R.F. van Vollenhoven⁵, ¹Stanford University, Portola Valley, CA, ²UCB Pharma, Brussels, Belgium, ³Adelphi Real World Ltd., Macclesfield, United Kingdom, ⁴Adelph Real World Ltd., Macclesfield, United Kingdom, ⁵Clinical Trials Unit Department of Rheumatology, The Karolinska Institute, Stockholm, Sweden
Background/Purpose: Current SLE treatment regimens follow an ‘add-on' paradigm: typically, therapies are added as the activity of a patient's disease increases. Most current treatments, particularly…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].